Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > The Game Begins
View:
Post by goldtech on Aug 06, 2024 1:14pm

The Game Begins

You are witnessing the highest levels of greed, ignorance and manipulation. So where are we? Phase 1B will start in about 60 days and that will dose 3 levels of patients, early, middle and late stage. In 6 months , probably 8 months from dosing we will get the results, show efficacy higher than 25% with no side effects and you have a win for AD. Remember Biogen increased its market cap by 40 Billion on the same news, will that happen, not likely, but a good rise regardless. Now here is what we can hope for, a joint Venture with huge cash upfront and huge milestones and 20% or more of net sales. The problem here is ignorance and that's our management team, very pathetic bunch. Now manipulation and greed takes over and if they are in this game to make all they can, then they will exercise all their warrants and direct the course of the company. The only problem I see here is deals done under the table and price fixing. If we prove that the collective coordinates work, then game on for PD, ALS, frontal temporal dementia and MSA. This this the best outcome, time will tell.
Comment by Gbathat on Aug 06, 2024 7:59pm
Our current market cap is $30M... so if we go up to $30B, I'll accept that :D  
Comment by Speyeder999 on Aug 07, 2024 11:27am
Speaking of our current market cap, when are the new issued shares come into play (15M new shares I presume ?) and the $30M in the company's coffers?   
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities